1032 related articles for article (PubMed ID: 16765759)
1. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.
; Connolly S; Pogue J; Hart R; Pfeffer M; Hohnloser S; Chrolavicius S; Pfeffer M; Hohnloser S; Yusuf S
Lancet; 2006 Jun; 367(9526):1903-12. PubMed ID: 16765759
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel plus aspirin vs oral anticoagulation for atrial fibrillation: the ACTIVE W trial.
DeSilvey DL
Am J Geriatr Cardiol; 2006; 15(5):326-7. PubMed ID: 16957455
[No Abstract] [Full Text] [Related]
3. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
4. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ
Stroke; 2008 May; 39(5):1482-6. PubMed ID: 18323500
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.
; ; Connolly S; Yusuf S; Budaj A; Camm J; Chrolavicius S; Commerford PJ; Flather M; Fox KA; Hart R; Hohnloser S; Joyner C; Pfeffer M; Anand I; Arthur H; Avezum A; Bethala-Sithya M; Blumenthal M; Ceremuzynski L; De Caterina R; Diaz R; Flaker G; Frangin G; Franzosi MG; Gaudin C; Golitsyn S; Goldhaber S; Granger C; Halon D; Hermosillo A; Hunt D; Jansky P; Karatzas N; Keltai M; Lanas F; Lau CP; Le Heuzey JY; Lewis BS; Morais J; Morillo C; Oto A; Paolasso E; Peters RJ; Pfisterer M; Piegas L; Pipillis T; Proste C; Sitkei E; Swedberg K; Synhorst D; Talajic M; Trégou V; Valentin V; van Mieghem W; Weintraub W; Varigos J
Am Heart J; 2006 Jun; 151(6):1187-93. PubMed ID: 16781218
[TBL] [Abstract][Full Text] [Related]
6. [Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)].
Meinertz T
Internist (Berl); 2007 Aug; 48(8):874-5. PubMed ID: 17628764
[No Abstract] [Full Text] [Related]
7. Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Blann AD; Skjøth F; Rasmussen LH; Larsen TB; Lip GY
Thromb Haemost; 2015 Aug; 114(2):403-9. PubMed ID: 26062437
[TBL] [Abstract][Full Text] [Related]
8. Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
; Connolly SJ; Pogue J; Hart RG; Hohnloser SH; Pfeffer M; Chrolavicius S; Yusuf S
N Engl J Med; 2009 May; 360(20):2066-78. PubMed ID: 19336502
[TBL] [Abstract][Full Text] [Related]
9. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.
Connolly SJ; Pogue J; Eikelboom J; Flaker G; Commerford P; Franzosi MG; Healey JS; Yusuf S;
Circulation; 2008 Nov; 118(20):2029-37. PubMed ID: 18955670
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel hydrogen sulphate for atrial fibrillation.
Garg N; Rajpurohit N; Flaker G
Expert Opin Pharmacother; 2011 Aug; 12(11):1781-7. PubMed ID: 21663525
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
[TBL] [Abstract][Full Text] [Related]
13. Irbesartan in patients with atrial fibrillation.
; Yusuf S; Healey JS; Pogue J; Chrolavicius S; Flather M; Hart RG; Hohnloser SH; Joyner CD; Pfeffer MA; Connolly SJ
N Engl J Med; 2011 Mar; 364(10):928-38. PubMed ID: 21388310
[TBL] [Abstract][Full Text] [Related]
14. [Preventing cerebrovascular accidents during atrial fibrillation].
Ederhy S; Meuleman C; Hammoudi N; Janower S; Boccara F; Cohen A
Presse Med; 2005 Oct; 34(18):1315-24. PubMed ID: 16269996
[TBL] [Abstract][Full Text] [Related]
15. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.
Connolly SJ; Eikelboom JW; Ng J; Hirsh J; Yusuf S; Pogue J; de Caterina R; Hohnloser S; Hart RG;
Ann Intern Med; 2011 Nov; 155(9):579-86. PubMed ID: 22041946
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet therapy for stroke prevention.
Hankey GJ
Curr Atheroscler Rep; 2007 Oct; 9(4):312-8. PubMed ID: 18173959
[TBL] [Abstract][Full Text] [Related]
17. Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
Steinberg BA; Kim S; Piccini JP; Fonarow GC; Lopes RD; Thomas L; Ezekowitz MD; Ansell J; Kowey P; Singer DE; Gersh B; Mahaffey KW; Hylek E; Go AS; Chang P; Peterson ED;
Circulation; 2013 Aug; 128(7):721-8. PubMed ID: 23861512
[TBL] [Abstract][Full Text] [Related]
18. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
[TBL] [Abstract][Full Text] [Related]
19. Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial.
Park SM; Jeong H; Jung MH; Hong KS; Hong MK; Bang CS; Kim CY
Contemp Clin Trials; 2017 Sep; 60():51-55. PubMed ID: 28642210
[TBL] [Abstract][Full Text] [Related]
20. Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W.
De Caterina R; Connolly SJ; Pogue J; Chrolavicius S; Budaj A; Morais J; Renda G; Yusuf S;
Eur Heart J; 2010 Sep; 31(17):2133-40. PubMed ID: 20685676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
